📖

Inflammatory Astrocytes in ALS

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-cell-types-inflammatory-astrocytes-
Related Entities
cell-types-inflammatory-astrocytes-als
Metadata
slugcell-types-inflammatory-astrocytes-als
entity_typecell
kg_node_idNone
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (111)
related🧫Macroautophagy Dysfunction in PD - Experiment Design70%
related🧫Macroautophagy Dysfunction in PD - Experiment Design70%
mentions🔬What are the mechanisms underlying tdp-43 phase separation t60%
mentions🔬What are the mechanisms underlying rna binding protein dysre60%
mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di60%
mentions🔬Analyze the spectrum of microglial activation states (DAM, h60%
mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di60%
mentions🔬RNA binding protein dysregulation across ALS FTD AD60%
mentions🔬TDP-43 undergoes liquid-liquid phase separation that becomes60%
mentions🔬RNA binding protein dysregulation across ALS FTD and AD60%
related🧫s:** - Single-cell RNA-seq to measure editing efficiency acr60%
related🧫Metabolic Pathway-Targeted Therapy in ALS60%
related🧫ALS Progression Rate Heterogeneity — mechanism and biomarker60%
related🧫ALS Regional Onset and Spread: Network-Level Staging Model60%
related🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk60%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri60%
related🧫Blood Biomarker vs Tau PET for Treatment Monitoring60%
related🧫Brainstem Circuit Modulation for PSP60%
related🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT60%
related🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study60%
related🧫Environmental Exposure Causal Attribution in ALS — Experimen60%
related🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio60%
related🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design60%
related🧫N-of-1 Clinical Trial Design for CBS/PSP60%
related🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers60%
related🧫Pre-Symptomatic Detection and Intervention Timing in Genetic60%
related🧫Progranulin Replacement Therapy for FTD — Vector Development60%
related🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD60%
related🧫PSP and CBS Biomarker Validation Study60%
related🧫Sleep and Respiratory Network Interaction in ALS — Experimen60%
related🧫TDP-43 PET Ligand Development for FTD and ALS60%
related🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des60%
related🔬What are the mechanisms underlying tdp-43 phase separation t54%
related🔬What are the mechanisms underlying rna binding protein dysre54%
related🔬CRISPR-based therapeutic approaches for neurodegenerative di54%
related🔬Analyze the spectrum of microglial activation states (DAM, h54%
related🔬CRISPR-based therapeutic approaches for neurodegenerative di54%
related🔬RNA binding protein dysregulation across ALS FTD AD54%
related🔬TDP-43 undergoes liquid-liquid phase separation that becomes54%
related🔬RNA binding protein dysregulation across ALS FTD and AD54%
related🧫s:** - Single-cell RNA-seq to measure editing efficiency acr54%
related🧫Metabolic Pathway-Targeted Therapy in ALS54%
related🧫ALS Progression Rate Heterogeneity — mechanism and biomarker54%
related🧫ALS Regional Onset and Spread: Network-Level Staging Model54%
related🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk54%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri54%
related🧫Blood Biomarker vs Tau PET for Treatment Monitoring54%
related🧫Brainstem Circuit Modulation for PSP54%
related🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT54%
related🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study54%
related🧫Environmental Exposure Causal Attribution in ALS — Experimen54%
related🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio54%
related🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design54%
related🧫N-of-1 Clinical Trial Design for CBS/PSP54%
related🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers54%
related🧫Pre-Symptomatic Detection and Intervention Timing in Genetic54%
related🧫Progranulin Replacement Therapy for FTD — Vector Development54%
related🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD54%
related🧫PSP and CBS Biomarker Validation Study54%
related🧫Sleep and Respiratory Network Interaction in ALS — Experimen54%
related🧫TDP-43 PET Ligand Development for FTD and ALS54%
related🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des54%
mentions🧫iPSC-NPC effects on astrocytes in vitro ICH model50%
mentions🧫Blood Biomarker vs Tau PET for Treatment Monitoring50%
mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation50%
mentions🧪Circadian Rhythm Entrainment of Reactive Astrocytes50%
mentions🧪Senescent Cell Mitochondrial DNA Release50%
mentions🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem50%
mentions🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener50%
mentions🧪Synthetic Biology BBB Endothelial Cell Reprogramming50%
mentions🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying selective vulnerability o50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬Comprehensive analysis of immune cell subtypes in neurodegen50%
related🔬What cell types are most vulnerable in Alzheimers Disease ba50%
related🔬What cell types are most vulnerable in Alzheimer's Dise50%
related🔬PSP and CBD both involve 4R-tau but produce distinct neuropa50%
related🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph50%
related🔬Microglia activate astrocytes via IL-1alpha/TNF/C1q, and rea50%
related🔬Senolytics targeting p16/p21+ senescent astrocytes and micro50%
related🔬Mitochondrial transfer between astrocytes and neurons50%
related🧪Mitochondrial RNA Granule Rescue Pathway50%
related🧪Axonal RNA Transport Reconstitution50%
related🧪RNA Granule Nucleation Site Modulation50%
mentions🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph40%
mentions🔬What are the mechanisms underlying mitochondrial transfer be40%
mentions🔬PSP and CBD both involve 4R-tau but produce distinct neuropa40%
mentions🔬Microglia activate astrocytes via IL-1alpha/TNF/C1q, and rea40%
mentions🔬Senolytics targeting p16/p21+ senescent astrocytes and micro40%
mentions🔬Mitochondrial transfer between astrocytes and neurons40%
mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen40%
mentions🔬What cell types are most vulnerable in Alzheimers Disease ba40%
mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%
related🧪Senescent Cell Mitochondrial DNA Release40%
related🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho40%
related🧪Circadian Rhythm Entrainment of Reactive Astrocytes40%
related🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem40%
related🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener40%
related🧪Synthetic Biology BBB Endothelial Cell Reprogramming40%
related🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho35%
related🧪Circadian Rhythm Entrainment of Reactive Astrocytes35%
related🔬What are the mechanisms underlying selective vulnerability o30%